å¢èæ§ç·ç¶ç(é«ç²åºŠåæ³ç©ãèåšã®åããé»å®³) èºãæšçãšãããCRISPRéºäŒåç·šéããŒã«è質ããç²å (LNP) ãéèããæ¥çš®ãåºåºå€åŽçµè·¯ãééãæšçã®æ²»çã«æåã | Ëê³âË) èºã¯å€çãšçŽæ¥æ¥ããåšå®ãªã®ã§ãåžå ¥ããç²åãç åäœãèºçŽ°èããé ãããé²åŸ¡æ©æ§ãåãããæ°éäžç®ããªã¢ãééããæ¹æ³ãä»ãŸã§ãããŸããã§ããã ä»åã®LNPç 究çµæã¯å€ãã®çŸæ£æ²»çã«å¿çšå¯èœã§æåŸ ãæãããŸãã éºäŒåæ²»çã¯æªã åé¡ãå«ãäºãããçºãé·æçãªèŠ³å¯ãè¡ãããäºãæãŸããŸãã Science 2024幎6æ13æ¥ www.science.org/doi/10.1126/...
ãç¥æ§ã®æ²èŠ³äž»çŸ©ïŒæå¿ã®æ¥œèŠ³äž»çŸ©ã ãèªèã¯æ²èŠ³çãè¡åã¯æ¥œèŠ³çã§ããã ã¢ã³ãããªã»ã°ã©ã ã· ãæ²èŠ³ã¯ææ ã楜芳ã¯æå¿ã ã¢ã©ã³(ãšããŒã«ïŒãªãŒã®ã¥ã¹ãã»ã·ã£ã«ãã£ãš) æå¿ãæã£ãŠãèºããŠãåçãšå ±ã«ç«ã¡äžãããäžæµã«ã楜芳çã«åãåããŠçªãé²ãäºã¯å€§äºã ã åãåããŠé ããèŠæ®ããã°ã空ãã足å ãäœãšãªãèŠããã¯ãã æ°å¹ŽåºŠã®çã®æåãç¥ããã
æ°å人ã®é害è ã "Covidæ²»çã®å·®ãæ§ã "ã§æ»äº¡ã調æ»ãž ã€ã®ãªã¹ãã³ããåæ ããŠã³çãèªéçããã®ä»ã®åŠç¿é害ãæã€å€ãã®äººã ã®å»çãã¡ã€ã«ã«ããŠã€ã«ã¹ã«ææããåã¯å¥åº·ã§ãã£ãã«ããããããããèçãããªã(DNAR)ããšããéç¥ã貌ãããŠããã t.co/l7w0bpqjJ0www.bbc.com/news/uk-poli...
æ°åã³ããæ¥æ§ææã»éå ¥é¢æ£è ã®åŸéºçè»è·¡ç 究 äžå€®å€39.8æ³ããã«ãŠã§ãŒãå䜵çç42% çãææåŸâ4ã¶æåŸ æ¥æ§äžæ°éçç¶ 40%â37% æ ¢æ§ç²åŽ å€ãããªã ç· åŒåžå°é£ 15%â25% è¶ èªç¥çç¶ 9%â32% èµ€ 鬱 1%â17% 玫 â»ç°è²ã¯å幎霢局ã®äœããã®æç ç ãã¯ã¯ãã³æ¥çš®ã§ç æ°äŒæççž®ããšèè 2024幎3æ5æ¥ www.frontiersin.org/journals/pub...
3/22çºè¡šã®ã€ã³ãã«ãšã³ã¶ææè å®ç¹å ±å(3/11ã3/17) ã»ææè æ°ã¯ãªãå¢å äžãæ°åŠæã»æ°ç掻ã»æéè¿äŒãªã©ã®ç§»åã§ãªãå¢å ãïŒ ã»æ°åã³ãããšéãå°å æ£è å ¥é¢æ°ããåŸæé«éœ¢è ãšäžŠãã§é«ããèŠæãïŒ ã»ç¹ã«æ°å€20以äžã®éœéåºçã¯å³é泚æïŒ
3/22çºè¡šã®æ°åã³ããææè å®ç¹å ±å(3/11ã3/17) ã»ææè æ°ã¯é«æ¢ãŸããæ°åŠæã»æ°ç掻ã»æéè¿äŒãªã©ã®ç§»åã§ãã®ãŸãŸç¬¬11æ³¢ãïŒ ã»æææè 垯ã¯10æ³æªæºå ãææè ã¯å°ãªããé«éœ¢è ã®å ¥é¢çé«ã泚æã ã»12æ³æªæºã«äœ¿ããæãŠã€ã«ã¹è¬ãªãã®ã§ã¯ã¯ãã³æ€èšãïŒ ã»åŸéºçæãã®ã§è¬æ€èšãïŒ
é«ã¯ã¯ãã³æ¥çš®ç+äœæé²éå£ã§ã18%ãå€å²ã«ãããã³ããåŸéºçãçµéšã å€ãã¯1ã¶æ以å ã«è·å ŽåŸ©åž°ããããã³ããçç¶+åŸéºçãåå ã§å®å šã«ã¯åŸ©åž°ã§ããªãå±€ãååšããåŸéºç18%ã®å 38%ã¯2ã3ã¶æåŸãŸã§æ²»çãäœåãªããããŠããã äžççã«åŸéºçæ²»çç 究ã«æ¬è °ãå ¥ããªããšãçµæžæŽ»åãã®ä»ã«ã圱é¿åºãã®ã§ãæ¬è °å ¥ããªããšã MJA 2024幎3æ20æ¥ onlinelibrary.wiley.com/doi/10.5694/...
å·«å±±æ¯ããªïŒãã©ãã°ïŒå·«å±±æ¯ããªïŒð¢ ðºðžã§ã¯æ°å¹Žããªããªã€ã系麻è¬(ã±ã·è£œ)ãã§ã³ã¿ãã«ã§èšå€§ãªæ°ã®æ»è ãåºãã18ã49æ³æ»äº¡åå äžäœã¯ãã§ã³ã¿ãã«ãã¢ã«ããã®100å匷åãšèšãããŠããã ããã®100å匷åãªã«ã«ãã§ã³ã¿ãã«ãåºåãå§æ«ã èŽæ»éã¯ããã€ã³30ã100mgããã§ã³ã¿ãã«2mgãã«ã«ãã§ã³ã¿ãã«0.02mgã 颚ã§èãäžãã£ã麻è¬ãææ»å®ãåžã蟌ãã ãã§èŽæ»ãäŸåã«äŸµãããã æ ã«ã¢ã¡ãªã«æ¿åºã麻è¬ãšã®æŠãã®æ¿çãæã¡åºããã ãã§ã³ã¿ãã«æ®æè¬ããããœã³ããæãã§ã³ã¿ãã«ã¯ã¯ãã³ãªã©ã䜿çšãããå§æ«ã
4/1ããæ°åã³ãã æ²»çè¬å ¬è²»è£å©ãªããªããŸãã 3å²è² æ 㧠ã»ãŸã³ãŒããçŽ15000å (7æ¥) ã»ã©ã²ããªãªãçŽ20000å (5æ¥) ã»ãã¯ã«ãªãŒç¹æ»ŽãçŽ100000å (4~6æ¬) ã»ã¯ã¯ãã³ãçŽ7000å ã»å ¥é¢è£å©ãªã è¬ã¯ã³ããåŸéºçã§ã䜿çšãããŠãã®ã§ããã€ã èŸãå Žåã¯åŸéºçå¿é ãªã®ã§ãæ²»çè¬éžæãã å ã¿ã«ãæææè 垯ã¯10æ³æªæºãäžåã®é£ç¶äžäœã ãã®å¹Žä»£ã®åäŸã«äœ¿ããæãŠã€ã«ã¹è¬ãç¡ããã§ãããâŠ(12æ³ãã) è³ãŸã§è¡ãã®åãã£ãŠãŸããããã¯ã¯ãã³ã§é²åŸ¡ããŠãã ãããšããã åŸæããŠããã§ã¯é ãã§ãããã埡æ€èšãã
COVID-19ããç¥çµçŽ°èâïžã¢ã¹ãããµã€ãâïžè¡ç®¡ã®æ é€ãªã©ã®ããåããããŠããéšäœã«çµå â Neurovascular coupling impairment (ç¥çµè¡ç®¡çµåé害)ãèªå° âæ é€äžè¶³ãªã©ããèšæ¶é害ãèªå° ãå€æãç¥çµè¡ç®¡çµåéšã®ãŠã€ã«ã¹é€å»ã§èšæ¶é害ãæ²»ãå¯èœæ§ã Brain Communications 2024幎3æ7æ¥ academic.oup.com/braincomms/a...